Clinical Trials Browser

Smoldering Multiple Myeloma × Denosumab × 1 year × Clear all

NCT03839459 2026-01-28

Denosumab for Smoldering Multiple Myeloma

Phase 2 Completed

20 enrolled 8 charts

Smoldering Multiple Myeloma